0001140361-23-029899.txt : 20230614 0001140361-23-029899.hdr.sgml : 20230614 20230614182754 ACCESSION NUMBER: 0001140361-23-029899 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230613 FILED AS OF DATE: 20230614 DATE AS OF CHANGE: 20230614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maples Sharon J. CENTRAL INDEX KEY: 0001524612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22427 FILM NUMBER: 231015471 MAIL ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 FORMER NAME: FORMER CONFORMED NAME: Larson Sharon J. DATE OF NAME CHANGE: 20170223 FORMER NAME: FORMER CONFORMED NAME: Riley Sharon L. DATE OF NAME CHANGE: 20110629 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HESKA CORP CENTRAL INDEX KEY: 0001038133 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 770192527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 BUSINESS PHONE: 9704937272 MAIL ADDRESS: STREET 1: 3760 ROCKY MOUNTAIN AVENUE CITY: LOVELAND STATE: CO ZIP: 80538 4 1 form4.xml X0407 4 2023-06-13 true 0001038133 HESKA CORP HSKA 0001524612 Maples Sharon J. 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 true false Common Stock 2023-06-13 4 D 0 8608 120 D 0 D Non-Qualified Stock Option (right to buy) 39.56 2023-06-13 4 D 0 3571 D 2016-05-13 2026-05-12 Common Stock 3571 0 D Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, in exchange for cash consideration of $120.00 per share of common stock of the Issuer (the "Merger Consideration") on the effective date of the merger. Stock options of the Issuer were canceled in the merger in exchange for an amount in cash equal to the difference, if any, between the Merger Consideration and the exercise price of such stock options. /s/ By: Catherine Grassman For: Sharon J. Maples 2023-06-13